Pfizer forms new human healthcare organisation

Pfizer has creatged a new organisation, Pfizer Human Healthcare, which brings together Pfizer Global Research and Development (PGRD), Pfizer Global Pharmaceuticals (PGP) and Pfizer Global Manufacturing (PGM) to enable the company to take advantage of its global scale in the core business of human pharmaceuticals.

The new organisation's leadership team will be chaired by Dr Hank McKinnell, Pfizer chairman and ceo. 'Over the past four years, we acquired two global healthcare companies - Warner-Lambert and Pharmacia - and divested a group of non-core businesses to focus even more intensely our core human pharmaceuticals business. Almost 90% of our revenues derives from the medicines we discover, develop, or license for the benefit of patients worldwide,' he said.

'Pfizer's continued success in the pharmaceutical business hinges on the alignment of our research, commercial and manufacturing operations. Increasingly, our strategies and tactics span all three of these groups, and to meet our global business objectives we are moving now to integrate them with closely co-ordinated planning and action. Our primary goal is end-to-end alignment across the full range of our global pharmaceutical business.'

Dr Peter Corr, currently senior vice president of science and technology, will focus his leadership efforts on product licensing, the development of scientific partnerships, medical relations and science policy. Meanwhile Dr John LaMattina, who currently heads Pfizer's worldwide research, is named president, Pfizer Global Research and Development.